Richard Gaynor
Patrimonio netto: 3 M $ in data 30/06/2026
Patrimonio netto: 3 M $ in data 30/06/2026
Richard Brian Gaynor is currently Director at Alkermes, Inc. since 2019, Director at The Damon Runyon Cancer Research Foundation, Independent Director at Alkermes Plc since 2019, and Independent Director at Zai Lab Ltd. since 2021.
Former positions include Independent Director at Infinity Pharmaceuticals, Inc. from 2020 to 2024, President-Research & Development at BioNTech US, Inc. from 2016 to 2020, Vice President-Clinical Development at Eli Lilly & Co. from 2002 to 2015, Senior VP-Clinical Development & Medical Affairs at Lilly Oncology, Director-Simmons Cancer Center at The University of Texas Southwestern Medical Center from 1998 to 2002, and Director & Chief-Hematology at Harold C Simmons Comprehensive Cancer Center.
Education includes undergraduate studies at Texas Tech University and a doctorate from The University of Texas Southwestern Medical Center.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 21/05/2026 | 35.751 ( 0,02% ) | 2 M $ | 30/06/2026 | |
ZAI LAB LTD. 0,07% | 01/07/2026 | 807.370 ( 0,07% ) | 1 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ALKERMES PLC | Direttore/Membro del Consiglio | 12/09/2019 |
| ZAI LAB LIMITED | Direttore/Membro del Consiglio | 19/11/2021 |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Supports cancer research | Direttore/Membro del Consiglio | - |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Direttore/Membro del Consiglio | 01/09/2019 |
| Società | Posizione | Fine |
|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/03/2024 |
| NEON THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2020 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/10/2016 |
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/08/2002 |
Lilly Oncology
Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Texas Tech University
Texas Tech University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services Supports cancer research | Commercial Services |
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lilly Oncology
Lilly Oncology Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Alkermes Plc
Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
BioNTech US, Inc.
BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Harold C Simmons Comprehensive Cancer Center |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale